North America Point of Care Molecular Diagnostics Market Size, Share & Industry Trends Analysis Report By Product & Service, By End User, By Technology, By Application, By Country and Growth Forecast, 2023

List of Tables

The North America Point of Care Molecular Diagnostics Market would witness market growth of 9.5% CAGR during the forecast period (2023-2030).

The healthcare system in the United States is sophisticated and well-organized. Additionally, the system supports R&D. The regulations promote foreign companies' entry into the US and the North American market. A large increase has also aided the growth of the market in new introductions. Molecular diagnostics has led the response to the COVID-19 pandemic. for instance, a study titled "Point-of-Care PCR Assays for COVID-19 Detection" published in the US National Library of Medicine claimed that reverse transcriptase-polymerase chain reaction (RT-PCR) and the quantitative variant (qRT-PCR) were considered the gold standard for COVID-19 diagnosis. However, there are several restrictions on molecular diagnostic technology.

As an instance, a research paper titled "Molecular diagnostic technologies for COVID-19: Limitations and challenges," published in the US National Library of Medicine in November 2020, explained that modern molecular diagnostics are not intended for point-of-care diagnosis of COVID-19 however, offer a core diagnostic solution for carrying out a large number of tests in a reasonable amount of time. Therefore, a precise diagnosis is essential to stop the spread of the illness. Such investigations deepen our understanding of the uses and constraints of molecular diagnostic tools. Product introductions are another component in the market's expansion.

The United States has the highest rate of cancer prevalence. The American Cancer Society estimates that 608,570 cancer deaths and 1,898,160 new cancer cases will be diagnosed in the United States in 2021. The same source also said that 90,222 cancer-related fatalities and 195,499 new cancer cases are anticipated in Mexico in 2020. The market is anticipated to grow even more due to the region's strong demand being matched by companies.

The US market dominated the North America Point of Care Molecular Diagnostics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,103.2 million by 2030. The Canada market is showcasing a CAGR of 11.9% during (2023 - 2030). Additionally, The Mexico market would experience a CAGR of 11% during (2023 - 2030).

Based on Product & Service, the market is segmented into Assays & Kits, Instruments & Analyzers and Software & Services. Based on End User, the market is segmented into Physicians Offices, Hospitals & ICUs, Research Institutes and Others. Based on by Technology, the market is segmented into RT-PCR, Isothermal Nucleic Acid Amplification Technology (INAAT) and Others. Based on Application, the market is segmented into Respiratory Diseases, Hospital-acquired Infections, Sexually Transmitted Diseases, Cancer, Hepatitis, Gastrointestinal Disorders and Others.Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Bayer AG, F. Hoffmann-La Roche Ltd., Qiagen N.V., Danaher Corporation, Bio-Rad Laboratories, Inc., BioMerieux S.A., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., and Nova Biomedical Corporation

Scope of the Study

Market Segments covered in the Report:

By Product & Service

Assays & Kits
Instruments & Analyzers
Software & Services Surveillance & Monitoring

By End User

Physicians Offices
Hospitals & ICUs
Research Institutes
Others

By Technology

RT-PCR
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others

By Application

Respiratory Diseases
Hospital-acquired Infections
Sexually Transmitted Diseases
Cancer
Hepatitis
Gastrointestinal Disorders
Others

By Country

US
Canada
Mexico
Rest of North America

Companies Profiled

Abbott Laboratories
Bayer AG
F. Hoffmann-La Roche Ltd.
Qiagen N.V.
Danaher Corporation
Bio-Rad Laboratories, Inc.
BioMerieux S.A.
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Nova Biomedical Corporation

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Point of Care Molecular Diagnostics Market, by Product & Service
- 1.4.2 North America Point of Care Molecular Diagnostics Market, by End User
- 1.4.3 North America Point of Care Molecular Diagnostics Market, by Technology
- 1.4.4 North America Point of Care Molecular Diagnostics Market, by Application
- 1.4.5 North America Point of Care Molecular Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)

Chapter 4. North America Point of Care Molecular Diagnostics Market by Product & Service

4.1 North America Assays & Kits Market by Country
4.2 North America Instruments & Analyzers Market by Country
4.3 North America Software & Services Market by Country

Chapter 5. North America Point of Care Molecular Diagnostics Market by End User

5.1 North America Physicians Offices Market by Country
5.2 North America Hospitals & ICUs Market by Country
5.3 North America Research Institutes Market by Country
5.4 North America Others Market by Country

Chapter 6. North America Point of Care Molecular Diagnostics Market by Technology

6.1 North America RT-PCR Market by Country
6.2 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country
6.3 North America Others Market by Country

Chapter 7. North America Point of Care Molecular Diagnostics Market by Application

7.1 North America Respiratory Diseases Market by Country
7.2 North America Hospital-acquired Infections Market by Country
7.3 North America Sexually Transmitted Diseases Market by Country
7.4 North America Cancer Market by Country
7.5 North America Hepatitis Market by Country
7.6 North America Gastrointestinal Disorders Market by Country
7.7 North America Others Market by Country

Chapter 8. North America Point of Care Molecular Diagnostics Market by Country

8.1 US Point of Care Molecular Diagnostics Market
- 8.1.1 US Point of Care Molecular Diagnostics Market by Product & Service
- 8.1.2 US Point of Care Molecular Diagnostics Market by End User
- 8.1.3 US Point of Care Molecular Diagnostics Market by Technology
- 8.1.4 US Point of Care Molecular Diagnostics Market by Application
8.2 Canada Point of Care Molecular Diagnostics Market
- 8.2.1 Canada Point of Care Molecular Diagnostics Market by Product & Service
- 8.2.2 Canada Point of Care Molecular Diagnostics Market by End User
- 8.2.3 Canada Point of Care Molecular Diagnostics Market by Technology
- 8.2.4 Canada Point of Care Molecular Diagnostics Market by Application
8.3 Mexico Point of Care Molecular Diagnostics Market
- 8.3.1 Mexico Point of Care Molecular Diagnostics Market by Product & Service
- 8.3.2 Mexico Point of Care Molecular Diagnostics Market by End User
- 8.3.3 Mexico Point of Care Molecular Diagnostics Market by Technology
- 8.3.4 Mexico Point of Care Molecular Diagnostics Market by Application
8.4 Rest of North America Point of Care Molecular Diagnostics Market
- 8.4.1 Rest of North America Point of Care Molecular Diagnostics Market by Product & Service
- 8.4.2 Rest of North America Point of Care Molecular Diagnostics Market by End User
- 8.4.3 Rest of North America Point of Care Molecular Diagnostics Market by Technology
- 8.4.4 Rest of North America Point of Care Molecular Diagnostics Market by Application

Chapter 9. Company Profiles

9.1 Abbott Laboratories
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 SWOT Analysis
9.2 Bayer AG
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 SWOT Analysis
9.3 Thermo Fisher Scientific, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expenses
- 9.3.5 Recent strategies and developments:
  - 9.3.5.1 Acquisition and Mergers:
- 9.3.6 SWOT Analysis
9.4 F. Hoffmann-La Roche Ltd.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 Recent strategies and developments:
  - 9.4.5.1 Partnerships, Collaborations, and Agreements:
  - 9.4.5.2 Product Launches and Product Expansions:
  - 9.4.5.3 Acquisition and Mergers:
9.5 BioMerieux S.A.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expenses
- 9.5.5 Recent strategies and developments:
  - 9.5.5.1 Partnerships, Collaborations, and Agreements:
  - 9.5.5.2 Acquisition and Mergers:
9.6 Qiagen N.V.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Regional Analysis
- 9.6.4 Research & Development Expense
- 9.6.5 Recent strategies and developments:
  - 9.6.5.1 Partnerships, Collaborations, and Agreements:
9.7 Danaher Corporation
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expense
9.8 Bio-Rad laboratories, Inc.
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expenses
- 9.8.5 Recent strategies and developments:
  - 9.8.5.1 Acquisition and Mergers:
9.9 Agilent Technologies, Inc.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Segmental and Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 Recent strategies and developments:
  - 9.9.5.1 Partnerships, Collaborations, and Agreements:
9.10. Nova Biomedical Corporation
- 9.10.1 Company Overview

LIST OF TABLES

TABLE 1 North America Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 2 North America Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements- Point of Care Molecular Diagnostics Market
TABLE 4 Product Launches And Product Expansions- Point of Care Molecular Diagnostics Market
TABLE 5 Acquisition and Mergers- Point of Care Molecular Diagnostics Market
TABLE 6 North America Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 7 North America Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 8 North America Assays & Kits Market by Country, 2019 - 2022, USD Million
TABLE 9 North America Assays & Kits Market by Country, 2023 - 2030, USD Million
TABLE 10 North America Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
TABLE 11 North America Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
TABLE 12 North America Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 13 North America Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 14 North America Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 15 North America Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 16 North America Physicians Offices Market by Country, 2019 - 2022, USD Million
TABLE 17 North America Physicians Offices Market by Country, 2023 - 2030, USD Million
TABLE 18 North America Hospitals & ICUs Market by Country, 2019 - 2022, USD Million
TABLE 19 North America Hospitals & ICUs Market by Country, 2023 - 2030, USD Million
TABLE 20 North America Research Institutes Market by Country, 2019 - 2022, USD Million
TABLE 21 North America Research Institutes Market by Country, 2023 - 2030, USD Million
TABLE 22 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 23 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 24 North America Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 25 North America Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 26 North America RT-PCR Market by Country, 2019 - 2022, USD Million
TABLE 27 North America RT-PCR Market by Country, 2023 - 2030, USD Million
TABLE 28 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2019 - 2022, USD Million
TABLE 29 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2023 - 2030, USD Million
TABLE 30 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 31 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 32 North America Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 33 North America Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 34 North America Respiratory Diseases Market by Country, 2019 - 2022, USD Million
TABLE 35 North America Respiratory Diseases Market by Country, 2023 - 2030, USD Million
TABLE 36 North America Hospital-acquired Infections Market by Country, 2019 - 2022, USD Million
TABLE 37 North America Hospital-acquired Infections Market by Country, 2023 - 2030, USD Million
TABLE 38 North America Sexually Transmitted Diseases Market by Country, 2019 - 2022, USD Million
TABLE 39 North America Sexually Transmitted Diseases Market by Country, 2023 - 2030, USD Million
TABLE 40 North America Cancer Market by Country, 2019 - 2022, USD Million
TABLE 41 North America Cancer Market by Country, 2023 - 2030, USD Million
TABLE 42 North America Hepatitis Market by Country, 2019 - 2022, USD Million
TABLE 43 North America Hepatitis Market by Country, 2023 - 2030, USD Million
TABLE 44 North America Gastrointestinal Disorders Market by Country, 2019 - 2022, USD Million
TABLE 45 North America Gastrointestinal Disorders Market by Country, 2023 - 2030, USD Million
TABLE 46 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 47 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 48 North America Point of Care Molecular Diagnostics Market by Country, 2019 - 2022, USD Million
TABLE 49 North America Point of Care Molecular Diagnostics Market by Country, 2023 - 2030, USD Million
TABLE 50 US Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 51 US Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 52 US Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 53 US Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 54 US Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 55 US Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 56 US Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 57 US Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 58 US Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 59 US Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 60 Canada Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 61 Canada Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 62 Canada Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 63 Canada Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 64 Canada Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 65 Canada Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 66 Canada Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 67 Canada Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 68 Canada Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 69 Canada Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 70 Mexico Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 71 Mexico Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 72 Mexico Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 73 Mexico Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 74 Mexico Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 75 Mexico Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 76 Mexico Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 77 Mexico Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 78 Mexico Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 79 Mexico Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 80 Rest of North America Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 81 Rest of North America Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 82 Rest of North America Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 83 Rest of North America Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 84 Rest of North America Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 85 Rest of North America Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 86 Rest of North America Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 87 Rest of North America Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 88 Rest of North America Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 89 Rest of North America Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 90 Key Information - Abbott Laboratories
TABLE 91 Key Information - Bayer AG
TABLE 92 Key Information - Thermo Fisher Scientific, Inc.
TABLE 93 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
TABLE 94 Key information - BioMerieux S.A.
TABLE 95 Key Information - Qiagen N.V.
TABLE 96 Key Information - Danaher Corporation
TABLE 97 Key Information - Bio-Rad Laboratories, Inc.
TABLE 98 key Information - Agilent Technologies, Inc.
TABLE 99 key information - Nova Biomedical Corporation

List of Figures

FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 North America Point of Care Molecular Diagnostics Market share by Product & Service, 2022
FIG 5 North America Point of Care Molecular Diagnostics Market share by Product & Service, 2030
FIG 6 North America Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2030, USD Million
FIG 7 North America Point of Care Molecular Diagnostics Market share by End User, 2022
FIG 8 North America Point of Care Molecular Diagnostics Market share by End User, 2030
FIG 9 North America Point of Care Molecular Diagnostics Market by End User, 2019 - 2030, USD Million
FIG 10 North America Point of Care Molecular Diagnostics Market share by Technology, 2022
FIG 11 North America Point of Care Molecular Diagnostics Market share by Technology, 2030
FIG 12 North America Point of Care Molecular Diagnostics Market by Technology, 2019 - 2030, USD Million
FIG 13 North America Point of Care Molecular Diagnostics Market share by Application, 2022
FIG 14 North America Point of Care Molecular Diagnostics Market share by Application, 2030
FIG 15 North America Point of Care Molecular Diagnostics Market by Application, 2019 - 2030, USD Million
FIG 16 North America Point of Care Molecular Diagnostics Market share by Country, 2022
FIG 17 North America Point of Care Molecular Diagnostics Market share by Country, 2030
FIG 18 North America Point of Care Molecular Diagnostics Market by Country, 2019 - 2030, USD Million
FIG 19 Swot Analysis: Abbott Laboratories
FIG 20 Swot Analysis: Bayer AG
FIG 21 Swot Analysis: Thermo Fisher Scientific, Inc.
FIG 22 Recent strategies and developments: F. Hoffmann-La Roche Ltd.

North America Point of Care Molecular Diagnostics Market Size, Share & Industry Trends Analysis Report By Product & Service, By End User, By Technology, By Application, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents